Subsequent tissue-specific ALK-overexpressing mouse models have been constructed that demonstrate synergy with MYCN in the ability to generate neuroblastoma [17,18] and have helped to clarify the oncogenic role of ALK, but, similarly, little is known about its physiological function. The gene discussed is ALK; the disease is neuroblastoma.